Aileron Therapeutics (NASDAQ:ALRN) Rating Increased to Hold at Zacks Investment Research

Retrieved on: 2020-01-04 19:55:36

Tags for this article:

Click the tags to see associated articles and topics

Aileron Therapeutics (NASDAQ:ALRN) Rating Increased to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

<div>Aileron Therapeutics, Inc. is based in Cambridge, Massachusetts. “ ... Finally, <b>BlackRock Inc</b>. raised its position in shares of Aileron Therapeutics by ...</div>

Article found on:

View Original Article